UKGrowth Network

UK company record

Sitryx Therapeutics

Immunometabolism (autoimmune/inflammatory disease)

CandidateCore UK
Open interactive recordCompanies House profile

Snapshot

UK location
Oxford · South East
Sector
Biotech & techbio
Latest recorded round
Series B (described in source as 'additional financing' - letter not explicit)
Latest recorded amount
$39M / £32M
Date
2023-09-01

Legal-identity layer

Candidate identity.

Selected legal name
SITRYX THERAPEUTICS LIMITED
Company number
10366466
Companies House status
active
Incorporated
2016-09-08

Investors

Current directors and active controllers

  • ALDRICH, RichardCurrent director
  • BHAMAN, MainaCurrent director
  • BINGHAM, Catherine Elizabeth, DameCurrent director
  • DEJONGH, SanneCurrent director
  • GRIGGS, Jeremy, DrCurrent director
  • KILTY, Iain CharlesCurrent director
  • LEGAULT, PierreCurrent director
  • ROBLING, James BradleyCurrent director
  • TAK, Paul-PeterCurrent director
  • TRBOVIC, NikolaCurrent director
  • WEIR, Andrew Neil Charles, DrCurrent director
  • ASHRAFIAN, Houman, Professordirector
  • CAVLAN, Olivia Rosemary Katesecretary
  • FARIS, Mellisa Annedirector
  • MODIS, Louise Kellydirector
  • PRINJHA, Rabinder Kumardirector
  • Professor Houman AshrafianFormer controller
  • RHYASEN, Garrettdirector
  • RICHTER, Henrijette Elsebethdirector
  • TINSLEY, Emmasecretary
  • TINSLEY, Emmadirector

Funding rows

Sources